SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Juhaeri Juhaeri · Study

Home/Author

Juhaeri Juhaeri

7 works· latest 2020· 1 institutionscluster: provisionalORCID 0000-0001-8235-8388

h-index7

i107

Citations565

Works here7

16

18

19

20

Most cited in this library

Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review2019 · 168 citations
Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review2018 · 91 citations
Recommendations for benefit–risk assessment methodologies and visual representations2016 · 78 citations
Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study2019 · 75 citations
Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review2019 · 57 citations

Works

7 shown

Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison

BMC Medical Informatics and Decision Making·2020·7 authors·Open access

48citations

Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study

Frontiers in Pharmacology·2019·19 authors·Open access

75citations

Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review

BMC Medical Informatics and Decision Making·2019·14 authors·review·Open access

57citations

Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review

Drug Discovery Today·2019·10 authors·review·Open access

168citations

Benefit–risk evaluation: the past, present and future

Therapeutic Advances in Drug Safety·2019·1 author·review·Open access

48citations

Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review

Drug Discovery Today·2018·11 authors·review·Open access

91citations

Recommendations for benefit–risk assessment methodologies and visual representations

Pharmacoepidemiology and Drug Safety·2016·15 authors·Open access

78citations